A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the cancer cell death/survival outcome according to p53 status

Alessia Garufi, Alessia Garufi, Silvia Baldari, Silvia Baldari, Riccardo Pettinari, Maria Saveria Gilardini Montani, Valerio D'orazi, Giuseppa Pistritto, Alessandra Crispini, Eugenia Giorno, Gabriele Toietta, Fabio Marchetti, Mara Cirone, Gabriella D'orazi

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the cancer cell death/survival outcome according to p53 status'. Together they form a unique fingerprint.

Medicine & Life Sciences